Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.
M BlanesJ I LorenzoP RibasA JiménezJ D GonzálezM J CejalvoC SolanoA AlegreJavier de la RubiaPublished in: Annals of hematology (2019)